FBI: Drugmaker Nostrum, CEO Agree to Pay Up to $50 Million to Resolve Claims of Underpaying Rebates Owed Under Medicaid Drug Rebate Program
November 01, 2023
November 01, 2023
BOSTON, Massachusetts, Nov. 1 -- The FBI issued the following news release on Oct. 30, 2023:
* * *
Drugmaker increased its price for Nitro OS from under $500 per bottle to over $2,300 per bottle
* * *
Nostrum Laboratories, Inc. (Nostrum), located in Missouri and New Jersey, and its founder and CEO Nirmal Mulye, Ph.D. (Mulye), have agreed to pay a minimum of $3,825,000 and up to $50 million if certain financial contingencies are met, to resolve . . .
* * *
Drugmaker increased its price for Nitro OS from under $500 per bottle to over $2,300 per bottle
* * *
Nostrum Laboratories, Inc. (Nostrum), located in Missouri and New Jersey, and its founder and CEO Nirmal Mulye, Ph.D. (Mulye), have agreed to pay a minimum of $3,825,000 and up to $50 million if certain financial contingencies are met, to resolve . . .